Acharya, Kalpana D.
Graham, Madeline
Raman, Harshini
Parakoyi, Abigail E. R.
Corcoran, Alexis
Belete, Merzu
Ramaswamy, Bharath
Koul, Shashikant
Sachar, Ishneet
Derendorf, Kevin
Wilmer, Jeremy B.
Gottipati, Srikanth
Tetel, Marc J.
Funding for this research was provided by:
National Institutes of Health (5U24DK076169-13 Subaward # 30835-64)
National Institute of Diabetes and Digestive and Kidney Diseases (NIH R01 DK61935)
Otsuka America Pharmaceutical
Article History
Received: 14 December 2022
Accepted: 17 March 2023
First Online: 23 March 2023
Competing interests
: SG, BR, MB, SK, and KD were employees of Otsuka Pharmaceutical Development and Commercialization, Inc. KD is a contractor for Otsuka Pharmaceutical Development and Commercialization. SG is currently an employee at Cerevel Therapeutics. The remaining authors declare no competing interests.